Case of acute‐onset type 1 diabetes induced by long‐term immunotherapy with nivolumab in a patient with mucosal melanoma

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus

“…Baseline characteristics are presented in Table 2 . In addition to our patients, 171 cases were identified [ 7 , 8 , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] , [73] , [74] , [...…”

Melanoma oral metastático: tratamento com radioterapia e nivolumabe

“…There was also hypothyroidism in the case reported by Kokkali et al, in which hormone replacement therapy was used. The reports by Liu et al 29 , Fukuchi et al 30 , Alzenald et al 31 and Maekawa, et al 32 identified vitiligo and diabetes.…”